Evidence map›Paper›PMID 33799365›Full record

ReviewMolecules (Basel, Switzerland)2021

Chalepin and Chalepensin: Occurrence, Biosynthesis and Therapeutic Potential.

Lutfun Nahar, Shaymaa Al-Majmaie, Afaf Al-Groshi, Azhar Rasul, Satyajit D Sarker

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Coumarin and Its Derivatives-Editorial.Molecules (Basel, Switzerland) · 2021
    Article
  9. Molecules (Basel, Switzerland) · 2021
    Review
  10. Article
  11. Furanocoumarins fromMolecules (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lutfun NaharLaboratory of Growth Regulators, Institute of Experimental Botany ASCR and Palacký University, Šlechtitelů 27, 78371 Olomouc, Czech Republic.ORCID 0000-0002-1157-2405
Shaymaa Al-MajmaieCentre for Natural Products Discovery, School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, James Parsons Building, Byrom Street, Liverpool L3 3AF, UK.
Afaf Al-GroshiCentre for Natural Products Discovery, School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, James Parsons Building, Byrom Street, Liverpool L3 3AF, UK.ORCID 0000-0003-4664-914X
Azhar RasulCell and Molecular Biology Lab, Department of Zoology, Government College University, Faisalabad 38000, Pakistan.ORCID 0000-0001-9669-7364
Satyajit D SarkerCentre for Natural Products Discovery, School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, James Parsons Building, Byrom Street, Liverpool L3 3AF, UK.ORCID 0000-0003-4038-0514

Funding

the European Regional Development Fund No. CZ.02.1.01/0.0/0.0/16_019/0000868
6 · The paper itself

Abstract

Dihydrofuranocoumarin, chalepin (

Indexed as

AnimalsClausenaCoumarinsFurocoumarinsHumansPlant ExtractsPlants, MedicinalRutaRutaceae3-(alpha,alpha-dimethylallyl)psoralenchalepinCoumarinsFurocoumarinsPlant ExtractsbioactivitybiosynthesischalepensinchalepinRutaceaeRuta chalepensis

Identifiers

PMID33799365
PMCPMC7999183

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.